Development of a prospective cohort of HIV Exposed Sero-Negative (HESN) individuals in Jos Nigeria.

Background HIV/AIDS continues to be a global health problem. With currently no cure, it is critical to get an effective vaccine to add to the arsenal of prevention and treatment tools. HIV Exposed Sero-Negative (HESN) individuals were enrolled and followed for 2 years.